Treace Medical Concepts (TMCI) said Friday its interim data from clinical trials of lapiplasty and adductoplasty to treat bunions and related mid-foot deformities showed low recurrence and continued improvement in pain.
Clinical study data of the two studies of lapiplasty procedure showed a return to protected weight bearing at an average of 7.9 and 8.4 days with recorded pain improvement at 12 months and 48 months.
Data from the study of adductoplasty procedure showed return to protected weight bearing at an average of 7.5 days with recorded pain improvement at 12 months.
The company presented the interim data at the 2025 American College of Foot and Ankle Surgeons Annual Meeting in Phoenix, Arizona.
Price: 8.50, Change: +0.13, Percent Change: +1.55
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。